X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215609
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215713
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-29-2022-1656479867.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212845
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-9-2022-1644385243.pdf
https://www.europeanpharmaceuticalreview.com/news/165376/drug-combination-an-alternative-leukaemia-treatment-to-chemotherapy/
https://www.pharmacompass.com/pdf/news/health-canada-issues-recall-of-new-almanic-internationals-splash-corporation-maxi-peel-exfoliant-product-recall-1591089586.pdf
http://www.pharmatimes.com/news/darzalex,_ibrance_among_latest_smc_decisions_1294142
https://www.fiercepharma.com/pharma-asia/foreign-drugmakers-under-threat-as-china-rolls-out-drug-list-to-boost-generic
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211644
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211645
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211645
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-22-2017-1490161550.pdf
http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208279
http://www.pharmatimes.com/news/eu_expands_scope_of_tevas_trisenox_1177797
http://www.pharma-excipients.ch/2016/08/14/nanostructured-lipid-carriers-for-the-topical-delivery-of-tretinoin/
http://www.prnewswire.com/news-releases/lonza-and-renova-therapeutics-announce-manufacturing-agreement-for-clinical-supply-of-rt-100-gene-therapy-300218125.html
http://www.prnewswire.com/news-releases/perrigo-completes-the-acquisition-of-generic-retin-a-portfolio-further-enhancing-rx-extended-topicals-strategy-300208947.html
http://www.prnewswire.com/news-releases/rich-pharmaceuticals-inc-receives-fda-approval-for-a-phase-12-study-in-aml--mds-300197153.html
http://www.prnewswire.com/news-releases/perrigo-acquires-generic-retin-a-portfolio-furthering-rx-extended-topicals-strategy-300194510.html
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/202564Orig1s000ltr.pdf
http://indianexpress.com/article/india/india-others/12-cancer-drugs-may-come-under-price-control/
Market Place
Share 
